Not applicableStudy completedNCT00946556
What this trial is testing
Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix
Who this might be right for
Herpes Simplex Type Two InfectionHIV Infections
University of Toronto 30